Progressive Supranuclear Palsy: Clinical Trials

2 trials for Progressive Supranuclear Palsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Progressive Supranuclear Palsy: new trials by email Literature Review of Progressive Supranuclear Palsy trials Research Report on Progressive Supranuclear Palsy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy
Rasagiline, Sugar pill - Progressive Supranuclear Palsy
Phase 3TerminatedProf. Dr. Stefan Lorenzl442010-01-012013-04-24
Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
Riluzole - Multiple System Atrophy, Progressive Supranuclear Palsy
Phase 3TerminatedKing's College London8002000-04-012005-12-15

Narrower conditions

Supranuclear Palsy, Progressive (2)  ·  Multiple System Atrophy (1)

Broader conditions

Basal Ganglia Diseases (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cranial Nerve Diseases (2)  ·  Eye Diseases (2)  ·  Movement Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurodegenerative Diseases (2)  ·  Neurologic Manifestations (2)  ·  Ocular Motility Disorders (2)  ·  Ophthalmoplegia (2)  ·  Paralysis (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Tauopathies (2)

Interventions

Riluzole (1)  ·  Sugars (1)  ·  rasagiline (1)

Sponsors

King's College London (1)  ·  Prof. Dr. Stefan Lorenzl (1)

Countries

Germany (1)  ·  United Kingdom (1)

Top investigators

Peter N Leigh, PhD FRCP (1)  ·  Stefan Lorenzl, PD Dr. (1)

Results publications

PMID 19029129, PMID 19771175, PMID 21386111, PMID 21829612

NIH funding

2008 (1)